Shenyang Xingqi Pharmaceutical Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100002DV1
CNY
70.26
0.89 (1.28%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
2,447.30
1,923.91
1,456.64
1,238.75
1,018.22
682.21
536.48
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,447.30
1,923.91
1,456.64
1,238.75
1,018.22
682.21
536.48
Raw Material Cost
506.25
457.60
364.80
288.38
256.13
201.94
160.12
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
4.83
6.52
1.89
1.75
6.84
6.44
4.65
Selling and Distribution Expenses
917.60
855.90
670.91
584.18
434.58
312.34
285.31
Other Expenses
20.39
20.22
15.53
13.34
7.27
4.99
4.36
Total Expenditure (Excl Depreciation)
1,632.57
1,522.17
1,192.89
1,007.70
770.25
570.64
493.69
Operating Profit (PBDIT) excl Other Income
814.7
401.70000000000005
263.7
231
248
111.6
42.800000000000004
Other Income
-0.18
-5.60
8.51
11.63
10.21
3.56
3.07
Operating Profit (PBDIT)
919.42
507.09
357.94
315.43
323.82
157.81
84.12
Interest
4.83
6.52
1.89
1.75
6.84
6.44
4.65
Exceptional Items
0.04
0.03
0.00
0.07
0.06
0.03
0.00
Gross Profit (PBDT)
1,941.05
1,466.31
1,091.84
950.37
762.08
480.27
376.36
Depreciation
114.35
105.57
91.06
80.03
73.50
48.86
43.66
Profit Before Tax
800.28
395.03
264.99
233.72
243.54
102.54
35.82
Tax
104.42
56.97
24.96
22.03
34.43
9.08
6.31
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
695.86
338.06
240.04
211.68
194.70
87.98
35.89
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
695.86
338.06
240.04
211.68
194.70
87.98
35.89
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
14.41
5.48
-6.38
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
695.86
338.06
240.04
211.68
209.11
93.46
29.51
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,978.05
1,593.17
1,689.92
1,552.31
1,344.49
682.19
568.51
Earnings per share (EPS)
2.83
1.38
0.98
0.87
0.81
0.39
0.16
Diluted Earnings per share
2.83
1.38
0.98
0.87
0.81
0.39
0.16
Operating Profit Margin (Excl OI)
32.9%
21.16%
17.74%
18.06%
23.58%
15.45%
6.97%
Gross Profit Margin
37.37%
26.02%
24.44%
25.33%
31.14%
22.19%
14.81%
PAT Margin
28.43%
17.57%
16.48%
17.09%
19.12%
12.9%
6.69%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 27.21% vs 32.08% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 105.83% vs 40.88% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 79.36% vs 46.74% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is -26.15% vs 242.11% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of Shenyang Xingqi Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
2,447.30
0
2,447.30
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,447.30
0
2,447.30
Raw Material Cost
506.25
0
506.25
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
4.83
0
4.83
Selling and Distribution Expenses
917.60
0
917.60
Other Expenses
20.39
0.00
20.39
Total Expenditure (Excl Depreciation)
1,632.57
0
1,632.57
Operating Profit (PBDIT) excl Other Income
814.74
0.00
814.74
Other Income
-0.18
0
-0.18
Operating Profit (PBDIT)
919.42
0
919.42
Interest
4.83
0
4.83
Exceptional Items
0.04
0
0.04
Gross Profit (PBDT)
1,941.05
0
1,941.05
Depreciation
114.35
0
114.35
Profit Before Tax
800.28
0
800.28
Tax
104.42
0
104.42
Provisions and contingencies
0
0
0.00
Profit After Tax
695.86
0
695.86
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
695.86
0
695.86
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
695.86
0
695.86
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,978.05
0
1,978.05
Earnings per share (EPS)
2.83
0
2.83
Diluted Earnings per share
2.83
0
2.83
Operating Profit Margin (Excl OI)
32.90%
0%
0.00
32.90%
Gross Profit Margin
37.37%
0%
0.00
37.37%
PAT Margin
28.43%
0%
0.00
28.43%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 244.73 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 27.21% vs 32.08% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 69.59 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 105.83% vs 40.88% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 91.96 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 79.36% vs 46.74% in Dec 2024

Annual - Interest
Interest 0.48 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -26.15% vs 242.11% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 32.90%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024